(Rev Alerg Mex[TA])
1,480 results
  • [Consensus of Mexican experts on long-term prophylaxis in patients with hereditary angioedema in Mexico]. [Journal Article]
    Rev Alerg Mex. 2026 Mar 31; 73(1):93-104.Guidos Fogelbach GA, Velasco Medina AA, … Piñeyro Beltrán EERA
  • CONCLUSIONS: HAE prophylaxis management in Mexico appears aligned with contemporary standards, yet sustained and individualized implementation remains limited by structural access and supply constraints. Key priorities include strengthening timely diagnosis, ensuring continuous access to targeted therapies, and standardizing follow-up in routine clinical care.
  • [Analysis of scientific production on asthma - COPD overlap syndrome]. [Systematic Review]
    Rev Alerg Mex. 2026 Mar 31; 73(1):66-75.Gonzáles Perleche JJ, Lescano Santos MN, Garca Solórzano FORA
  • CONCLUSIONS: The analysis of scientific production on ACO reveals that, despite the sustained increase in research, significant gaps persist regarding therapeutic strategies. Furthermore, research remains limited in several countries with a high disease burden; mapping these areas and regions will be essential to foster the generation of local evidence to guide clinical and public health decision-making.
  • [Prevalence of chronic prurigo in Argentina: A cross-sectional descriptive study]. [Journal Article]
    Rev Alerg Mex. 2026 Mar 31; 73(1):58-65.Wagner A, Di Prinzio A, … Torre ACRA
  • CONCLUSIONS: The prevalence of chronic prurigo in our cohort differs from that reported in other countries. Unlike previous studies, no statistically significant associations with other skin diseases were found. The treatment the patients received was inconsistent with that proposed in international guidelines.